Doherty researchers develop world-first AMR detection tool 

  23 February 2023

A new tool that could soon revolutionise the way we identify antimicrobial resistance (AMR) has been developed by researchers at the University of Melbourne’s Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), located at the Peter Doherty Institute for Infection and Immunity (Doherty Institute).

abritAMR is an ISO-certified bioinformatics platform that is able to find AMR determinants from whole genome sequencing data and separates the identified genes into functionally relevant groups. 

To date, the lack of international standards in the AMR genomics space has been a limiting factor in the ability to compare outputs from different laboratories, especially with regards to how that information is applied in the clinical context.

Further reading: Doherty Institute
Author(s): Doherty Institute
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed